Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Lymphoid Neoplasm — Trials · CancerIndex

Cancers
Lymphoid Neoplasm

Hematologic Malignancy

Lymphoid Neoplasm

CI-CAN-00009335Explore in graph →

Hematologic2,419 active trials60 approved drugs271 evidence items

OncoTree: LNM

Overview
Statistics
Survival
Genomics35
Variants & evidence271
Drugs47
Trials8885
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

8,885 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,268
Ph III recruiting: 131
Growth YoY: +6.7%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,373)

StatusAll Active (any)Completed 3,465 Recruiting 1,517 Unknown 1,111 Terminated 1,084 Active Not Recruiting 840 Not Yet Recruiting 428 Withdrawn 323 Suspended 37 Enrolling By Invitation 29 No Longer Available 27 Available 12 Approved For Marketing 12

PhaseAll Early Phase 1 204 N/A 619 Phase 1 2,909 Phase 2 4,268 Phase 3 803 Phase 4 146

No study matches these filters